Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte–macrophage colony-stimulating factor (GM-CSF)
- 1 October 2002
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 219 (2) , 92-97
- https://doi.org/10.1016/s0008-8749(02)00565-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSFThorax, 2002
- Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: Essential role of GM-CSF☆☆☆Journal of Allergy and Clinical Immunology, 1999
- Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia.Journal of Clinical Investigation, 1998
- Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of AsthmaThe Journal of Experimental Medicine, 1997
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.The Journal of Experimental Medicine, 1996
- Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.The Journal of Experimental Medicine, 1996
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.Journal of Clinical Investigation, 1990
- Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.Journal of Clinical Investigation, 1986
- Role of inflammation in the hyperreactivity of the airways in asthma.Thorax, 1986